Zobrazeno 1 - 10
of 498
pro vyhledávání: '"Zoran Gatalica"'
Autor:
Semir Vranic, Zoran Gatalica
Publikováno v:
Biomolecules & Biomedicine (2024)
Oncologic treatment has recently undergone substantial therapeutic paradigm shifts, from classical tumor-specific and biomarker-agnostic approaches to more molecular, biomarker-specific, and tumor-agnostic. Tumor-type (histology) agnostic drugs work
Externí odkaz:
https://doaj.org/article/e3f3a473c5bb43eaa8f371c5848cfc3e
Autor:
Zoran Gatalica, Nataliya Kuzmova, Inga Rose, Monika Ulamec, Melita Peric-Balja, Faruk Skenderi, Semir Vranic
Publikováno v:
Biomolecules & Biomedicine, Vol 24, Iss 2 (2024)
In the current study, we assessed the prevalence and molecular features of HER2-low phenotype in the apocrine carcinomas of the breast (ApoCa) and its relationship with tumor-infiltrating lymphocytes (TILs). A cohort of 64 well-characterized therapy-
Externí odkaz:
https://doaj.org/article/98174daa0c0d48888a0eeaa67441e2af
Autor:
Colleen Ziegler, Alain Mir, Sangeetha Anandakrishnan, Patrick Martin, Elma Contreras, Isaiah Slemons, Barbara Witkowski, Chris DeSilva, Andrew Farmer, Semir Vranic, Zoran Gatalica, David Richardson, Dmitry N. Derkach
Publikováno v:
Molecular Oncology, Vol 17, Iss 10, Pp 1953-1961 (2023)
The role of the tumor microenvironment (TME) in immuno‐oncology has driven demand for technologies that deliver in situ, or spatial, molecular information. Compartmentalized heterogeneity that traditional methods miss is becoming key to predicting
Externí odkaz:
https://doaj.org/article/3923b614bd924306b7a85645acc777c0
Autor:
Udayan Bhattacharya, Elangovan Thavathiru, Fiifi Neizer-Ashun, Chao Xu, Zoran Gatalica, Shailendra Kumar Dhar Dwivedi, Anindya Dey, Priyabrata Mukherjee, Resham Bhattacharya
Publikováno v:
npj Precision Oncology, Vol 6, Iss 1, Pp 1-6 (2022)
Abstract The ubiquitin-specific peptidase 10 (USP10) plays a context-specific, pro or anti-tumorigenic role in different malignancies. However, the role of USP10 in pancreatic cancer remains unclear. Our protein and RNA level analysis from archived s
Externí odkaz:
https://doaj.org/article/f9e506520bac47079ed9d9844cadea1e
Autor:
Azra Ajkunic, Faruk Skenderi, Nada Shaker, Saghir Akhtar, Janez Lamovec, Zoran Gatalica, Semir Vranic
Publikováno v:
Breast, Vol 66, Iss , Pp 208-216 (2022)
Acinic cell carcinoma of the breast is a rare special subtype of breast cancer in the category of salivary gland-type tumors. It is morphologically similar to acinic cell carcinomas of salivary glands and pancreas and has a triple-negative phenotype
Externí odkaz:
https://doaj.org/article/26871b29be484338a073d71153865ded
Publikováno v:
Cancers, Vol 15, Iss 20, p 5084 (2023)
Merkel cell carcinoma (MCC) is primarily a disease of the elderly Caucasian, with most cases occurring in individuals over 50. Immune checkpoint inhibitors (ICI) treatment has shown promising results in MCC patients. Although ~34% of MCC patients are
Externí odkaz:
https://doaj.org/article/5672f06b6b644326b98f3299e4e0162d
Autor:
Kresimir Tomic, Dragana Karan Krizanac, Faruk Skenderi, Kristina Krpina, Andrea Carapina Bilic, Kristina Galic, Zoran Gatalica, Semir Vranic
Publikováno v:
Respiratory Medicine Case Reports, Vol 45, Iss , Pp 101920- (2023)
Small cell lung cancer (SCLC) is a highly aggressive malignancy with a poor outcome. We present the case of a 57-year-old male patient with extensive-stage (ES-SCLC) treated with chemotherapy and atezolizumab. A complete response was achieved with a
Externí odkaz:
https://doaj.org/article/bbad840544084114a4314397604fe863
Autor:
Semir Vranic, Zoran Gatalica
Publikováno v:
Biomolecules & Biomedicine, Vol 23, Iss 1 (2023)
Immunotherapy, based on immune checkpoint inhibitors targeting the Programmed cell death ligand 1 (PD-L1) and/or Programmed Death Receptor 1 (PD-1), has substantially improved the outcomes of patients with various cancers. However, only ~30% of patie
Externí odkaz:
https://doaj.org/article/967ee5b7a3e7438ebb3aec263a20f2fd
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 4485-4503 (2021)
Nuclear protein of testis (NUT), a protein product of the NUTM1 gene (located on the long arm of chromosome 15) with highly restricted physiologic expression in post-meiotic spermatids, is the oncogenic driver of a group of emerging neoplasms when fu
Externí odkaz:
https://doaj.org/article/05b8d2bb57d140afaf59c58f3b21edd2
Autor:
Christopher Dardis, David Donner, Nader Sanai, Joanne Xiu, Sandeep Mittal, Sharon K. Michelhaugh, Manjari Pandey, Santosh Kesari, Amy B. Heimberger, Zoran Gatalica, Michael W. Korn, Ashley L. Sumrall, Surasak Phuphanich
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Gliosarcoma (GS) refers to the presence of mesenchymal differentiation (as seen using light microscopy) in the setting of glioblastoma (GB, an astrocytoma, WHO Grade 4). Although the same approach to treatment is typically adopted
Externí odkaz:
https://doaj.org/article/b836d9253b644586aa063e975f111f5f